Liposomes containing glycocholate as potential oral insulin delivery systems: preparation, in vitro characterization, and improved protection against enzymatic degradation.
about
Novel mucus-penetrating liposomes as a potential oral drug delivery system: preparation, in vitro characterization, and enhanced cellular uptakeEnhanced oral bioavailability of cyclosporine A by liposomes containing a bile saltPolymeric-based particulate systems for delivery of therapeutic proteins.Nanoemulsions as novel oral carriers of stiripentol: insights into the protective effect and absorption enhancement.Silica-coated flexible liposomes as a nanohybrid delivery system for enhanced oral bioavailability of curcuminNanoemulsions coated with alginate/chitosan as oral insulin delivery systems: preparation, characterization, and hypoglycemic effect in rats.Liquid crystal nanoparticle formulation as an oral drug delivery system for liver-specific distributionLiposomes containing bile salts as novel ocular delivery systems for tacrolimus (FK506): in vitro characterization and improved corneal permeation.Development of polyherbal antidiabetic formulation encapsulated in the phospholipids vesicle systemEnhanced hypoglycemic effect of biotin-modified liposomes loading insulin: effect of formulation variables, intracellular trafficking, and cytotoxicityFactors affecting the pharmacokinetics and pharmacodynamics of liposomal drugs.Strategies for non-invasive delivery of biologics.Drug carriers for oral delivery of peptides and proteins: accomplishments and future perspectives.Emerging micro- and nanotechnology based synthetic approaches for insulin delivery.Biologics: the role of delivery systems in improved therapy.Oral delivery of nanoparticle-based vaccines.Bile salts-containing vesicles: promising pharmaceutical carriers for oral delivery of poorly water-soluble drugs and peptide/protein-based therapeutics or vaccines.A review of biodegradable polymeric systems for oral insulin delivery.Multifaceted applications of bile salts in pharmacy: an emphasis on nanomedicineRecent advances in liposome surface modification for oral drug delivery.Nanocarriers protecting toward an intestinal pre-uptake metabolism.Sodium dodecyl sulfate/β-cyclodextrin vesicles embedded in chitosan gel for insulin delivery with pH-selective release.Enhanced oral bioavailability of silymarin using liposomes containing a bile salt: preparation by supercritical fluid technology and evaluation in vitro and in vivo.Experimental Evaluation of the Transport Mechanisms of PoIFN-α in Caco-2 Cells.Potential Applications of Gliclazide in Treating Type 1 Diabetes Mellitus: Formulation with Bile Acids and Probiotics.Improved hepatoprotective activity of silymarin via encapsulation in the novel vesicular nanosystem bilosomes.Biomimetic thiamine- and niacin-decorated liposomes for enhanced oral delivery of insulin.Facilitated permeation of insulin across TR146 cells by cholic acid derivatives-modified elastic bilosomes
P2860
Q34098017-8865D2AB-F6E8-4EB1-83AC-519316EA6ECEQ35071614-CE38031A-7E02-4BB3-A7B7-FD1C0F0C5C6EQ35539532-E4FFD1A6-8FBB-453E-993E-7DE794CFBFB9Q35924348-DE50A86B-2D8D-45C1-BD8E-1871F2F0FC9CQ36458029-42FDE692-5F51-4900-BFBE-C71C26CFB981Q36500104-B361891F-A390-4809-97FB-805F11E1FF88Q36659315-91F1FB83-8546-42EC-8E0C-AF139565CEE0Q36852078-804CF347-3D46-4D62-BA58-4ADF116CE367Q36965584-2C883FE7-BF66-4164-9DCE-464C3E23780EQ37718748-6A85FAEA-7D4F-4D4A-AE8F-A2707A6E018EQ37983912-E08DA6DD-7971-4B35-AC12-3C425E069638Q38013190-282BB686-A202-4BD5-89C3-38893540E737Q38076188-1FD9762B-DC95-492A-A994-DDE65D21D6B0Q38195730-E1B2FBF4-76A0-4276-A13C-1921437BF552Q38199664-2CFAE6EE-B77E-4785-A304-92AA6EB6C7D0Q38243119-1C29395F-364E-49BD-8BF6-D4C3F1577957Q38267521-14738A96-A800-4E1B-8DD4-67F0DC69DC43Q38525280-C239997D-E107-4D03-8C81-0B7132017A42Q38537527-06A2CA16-3686-4B96-87E3-A90A2FA9AC43Q38807276-4F4B08A3-A693-4568-B4CA-084F1B262D68Q39091552-8832EF60-E427-418B-A68D-7AA08803F31DQ42005087-FB67D113-9FF7-473B-ADAB-6C55528E4AF6Q42091649-CBE491CD-8386-4E15-AE64-BECD52C61F31Q46894151-5FDD3E74-7530-4A55-8BA3-819887950FBFQ48177243-3A3E8AF8-3E6C-429D-A1A8-9207142E72D5Q48324641-2424F979-290E-44B4-99E1-7B106A28AE4FQ55006868-9B7CCF8E-7597-4B86-BC62-FAB5BB5D972AQ57108890-0D5EBE10-79AF-4DCB-9A97-1695827C1B1D
P2860
Liposomes containing glycocholate as potential oral insulin delivery systems: preparation, in vitro characterization, and improved protection against enzymatic degradation.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Liposomes containing glycochol ...... against enzymatic degradation.
@en
type
label
Liposomes containing glycochol ...... against enzymatic degradation.
@en
prefLabel
Liposomes containing glycochol ...... against enzymatic degradation.
@en
P2093
P2860
P698
P1476
Liposomes containing glycochol ...... against enzymatic degradation
@en
P2093
Lars Hovgaard
Mengmeng Niu
P2860
P304
P356
10.2147/IJN.S19917
10.2217/NNM.11.116
P407
P50
P577
2011-06-08T00:00:00Z